135 related articles for article (PubMed ID: 38794291)
1. Using Polymers as Crystal Inhibitors to Prevent the Crystallization of the Rotigotine Patch.
Liu Q; Li X; Liu B; Kong J; Wang Q; Gao Z
Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794291
[TBL] [Abstract][Full Text] [Related]
2. Investigation on the effect of deep eutectic formation on drug-polymer miscibility and skin permeability of rotigotine drug-in-adhesive patch.
Liu C; Qu X; Song L; Shang R; Wan X; Fang L
Int J Pharm; 2020 Jan; 574():118852. PubMed ID: 31759103
[TBL] [Abstract][Full Text] [Related]
3. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
Ameen D; Michniak-Kohn B
Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
[TBL] [Abstract][Full Text] [Related]
4. Induction and inhibition of crystallization in drug-in-adhesive-type transdermal patches.
Jain P; Banga AK
Pharm Res; 2013 Feb; 30(2):562-71. PubMed ID: 23093376
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the bioavailability and adhesiveness of different rotigotine transdermal patch formulations.
Elshoff JP; Timmermann L; Schmid M; Arth C; Komenda M; Brunnert M; Bauer L
Curr Med Res Opin; 2013 Dec; 29(12):1657-62. PubMed ID: 24006953
[TBL] [Abstract][Full Text] [Related]
6. Formulation optimization of a drug in adhesive transdermal analgesic patch.
Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
[TBL] [Abstract][Full Text] [Related]
7. Drug crystallization - implications for topical and transdermal delivery.
Hadgraft J; Lane ME
Expert Opin Drug Deliv; 2016 Jun; 13(6):817-30. PubMed ID: 26766744
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of vitamin E TPGS/HPMC supersaturated system and other solubilizer/polymer combinations to enhance the permeability of a poorly soluble drug through the skin.
Ghosh I; Michniak-Kohn B
Drug Dev Ind Pharm; 2012 Nov; 38(11):1408-16. PubMed ID: 22296239
[TBL] [Abstract][Full Text] [Related]
9. Formulation optimization of a drug in adhesive transdermal analgesic patch.
Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
Drug Dev Ind Pharm; 2016 Jun; 42(6):862-870. PubMed ID: 26227813
[TBL] [Abstract][Full Text] [Related]
10. Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers.
Kapourani A; Tzakri T; Valkanioti V; Kontogiannopoulos KN; Barmpalexis P
Int J Pharm X; 2021 Dec; 3():100086. PubMed ID: 34151251
[TBL] [Abstract][Full Text] [Related]
11. Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy.
Zhao J; Xu Y; Wang C; Ding Y; Chen M; Wang Y; Peng J; Li L; Lv L
Drug Dev Ind Pharm; 2017 Jul; 43(7):1197-1204. PubMed ID: 28300426
[TBL] [Abstract][Full Text] [Related]
12. Revealing the roles of polymers in supersaturation stabilization from the perspective of crystallization behaviors: A case of nimodipine.
Zhao P; Hu G; Chen H; Li M; Wang Y; Sun N; Wang L; Xu Y; Xia J; Tian B; Liu Y; He Z; Fu Q
Int J Pharm; 2022 Mar; 616():121538. PubMed ID: 35124119
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of a novel drug delivery: Soluplus
Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L
Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714
[TBL] [Abstract][Full Text] [Related]
14. Synergetic effect of nucleation and crystal growth inhibitor on in vitro-in vivo performance of supersaturable lacidipine solid dispersion.
Guan J; Huan X; Liu Q; Jin L; Wu H; Zhang X; Mao S
Int J Pharm; 2019 Jul; 566():594-603. PubMed ID: 31175988
[TBL] [Abstract][Full Text] [Related]
15. Formulation of Polymers-Based Methotrexate Patches and Investigation of the Effect of Various Penetration Enhancers: In Vitro, Ex Vivo and In Vivo Characterization.
Latif MS; Nawaz A; Rashid SA; Akhlaq M; Iqbal A; Khan MJ; Khan MS; Lim V; Alfatama M
Polymers (Basel); 2022 May; 14(11):. PubMed ID: 35683883
[TBL] [Abstract][Full Text] [Related]
16. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of surface crystallisation of amorphous indomethacin particles in physical drug-polymer mixtures.
Priemel PA; Laitinen R; Barthold S; Grohganz H; Lehto VP; Rades T; Strachan CJ
Int J Pharm; 2013 Nov; 456(2):301-6. PubMed ID: 24012867
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Drug Loading in the Drug-in-Adhesive Transdermal Patch Utilizing a Drug-Ionic Liquid Strategy: Insight into the Role of Ionic Hydrogen Bonding.
Yang D; Liu C; Piao H; Quan P; Fang L
Mol Pharm; 2021 Mar; 18(3):1157-1166. PubMed ID: 33504154
[TBL] [Abstract][Full Text] [Related]
19. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
Tian Y; Jones DS; Andrews GP
Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle formulations as recrystallization inhibitors in transdermal patches.
Tahir MA; Ali ME; Lamprecht A
Int J Pharm; 2020 Feb; 575():118886. PubMed ID: 31790804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
